Hims & Hers Health, Inc. (HIMS) Misses Q2 EPS by 32c, Beats on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail.jpg)
Get Alerts HIMS Hot Sheet
Join SI Premium – FREE
Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.37), $0.32 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $753 million versus the consensus estimate of $691.65 million.
GUIDANCE:
Hims & Hers Health, Inc. sees FY2026 revenue of $3.1-3.3 billion, versus the consensus of $3.05 billion.
For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel shares fall as competitor reports record results
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- XPEL, Inc. (XPEL) Tops Q3 EPS by 4c, Misses on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
